PD15-11 SURVIVAL RATES AND ECONOMIC OUTCOMES IN CHEMOTHERAPY-NAïVE METASTATIC CASTRATE RESISTANT PROSTATE CANCER PATIENTS TREATED WITH ABIRATERONE ACETATE OR ENZALUTAMIDE | Zendy

AI Assistant Blog Pricing

PD15-11 SURVIVAL RATES AND ECONOMIC OUTCOMES IN CHEMOTHERAPY-NAïVE METASTATIC CASTRATE RESISTANT PROSTATE CANCER PATIENTS TREATED WITH ABIRATERONE ACETATE OR ENZALUTAMIDE

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.